Andrew London and Sam Hoff will lead a session at The Mass League Health Center Compliance Academy on January 20th. They will delve into the 340B Drug Pricing Program and its recent changes. This program helps community health centers access medicines at reduced costs.
In their talk, they’ll cover important topics like participation requirements, the Alternative Dispute Resolution (ADR) process, audits, the use of contract pharmacies, and how states are influencing access to these drugs.
During the session, participants can expect to:
- Explore the history and growth of the 340B program, along with its current rules.
- Gain insights into how ADR works and the role of the Health Resources and Services Administration (HRSA) in resolving disputes.
- Discuss new federal changes on manufacturer restrictions and the resulting legal challenges.
- Review the impact of manufacturer rebate policies and ongoing litigation surrounding them.
- Examine state-level trends affecting the 340B program and consider what this might mean for Massachusetts.
The 340B program is vital for many health centers. Recent data show that nearly 30% of community health centers rely on it to serve low-income patients. Understanding these changes will help health organizations navigate this complex landscape effectively.
For insights on the ongoing discussions about the 340B program, check out the HRSA’s official site.
